Article Information
History
- May 6, 2019.
Article Versions
- Version 1 (November 30, 2017 - 17:13).
- Version 2 (December 1, 2017 - 13:21).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Julius Muller1,
- Rachel Tanner1,
- Magali Matsumiya1,
- Margaret A. Snowden3,
- Bernard Landry3,
- Iman Satti1,
- Stephanie A. Harris1,
- Rachel Tanner1,
- Matthew K. O’Shea1,
- Lisa Stockdale1,2,
- Leanne Marsay1,
- Agnieszka Chomka1,4,
- Rachel Harrington-Kandt1,
- Zita-Rose Manjaly Thomas1,
- Vivek Naranbhai5,
- Elena Stylianou1,
- Stanley Kimbung Mbandi6,
- Mark Hatherill6,
- Gregory Hussey6,
- Hassan Mahomed6,
- Michele Tameris6,
- J. Bruce McClain3,
- Thomas G. Evans3,
- Willem A. Hanekom6,
- Thomas J. Scriba6,
- Helen McShane1 and
- Helen A. Fletcher1,2,*
- 1The Jenner Institute, University of Oxford, Oxford, UK, OX3 7DQ;
- 2London School of Hygiene & Tropical Medicine, London, UK, W1CE7HT;
- 3Aeras, Rockville, USA, MD 20850;
- 4The Kennedy Institute, University of Oxford, Oxford, UK, OX3 7LF;
- 5Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK, OX37B;
- 6South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine & Division of Immunology, Department of Pathology, University of Cape Town, South Africa, 7935.
- ↵*Corresponding author; email: helen.fletcher{at}lshtm.ac.uk